MedPage Today on MSN
Near-perfect disease control for bispecific in advanced endometrial cancer
Only one of 41 patients did not have at least stable disease with cadonilimab plus chemoth ...
SEATTLE & BOSTON--(BUSINESS WIRE)--Curi Bio, the industry leader in delivering human functional data to the drug discovery community, and Novoheart, maker of the industry’s most sophisticated and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results